Product References
Integrative modeling and analysis of signaling crosstalk reveal molecular switches coordinating Yes-associated protein transcriptional activities.
iScience
Ghomlaghi M,Theocharous M,Hoang N,Shin SY,von Kriegsheim A,O' Neill E,Zhang T,Nguyen LK
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Western Blot
Fri Mar 15 00:00:00 UTC 2024
Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma.
Life science alliance
Romano D,García-Gutiérrez L,Aboud N,Duffy DJ,Flaherty KT,Frederick DT,Kolch W,Matallanas D
14-6888-82 was used in Western Blotting to show that the MST2 pathway plays a role in the acquisition of BRAFi resistance in melanoma.
Sat Oct 01 00:00:00 UTC 2022
Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation.
Cell death and differentiation
Li W,Yue F,Dai Y,Shi B,Xu G,Jiang X,Zhou X,Pfeifer GP,Liu L
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Immunoprecipitation
Thu Aug 01 00:00:00 UTC 2019
Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation.
Cell death and differentiation
Li W,Yue F,Dai Y,Shi B,Xu G,Jiang X,Zhou X,Pfeifer GP,Liu L
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Immunoprecipitation
Thu Aug 01 00:00:00 UTC 2019
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer.
Cancers
Blanchard TG,Czinn SJ,Banerjee V,Sharda N,Bafford AC,Mubariz F,Morozov D,Passaniti A,Ahmed H,Banerjee A
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Western Blot
Fri Feb 08 00:00:00 UTC 2019
Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer.
Cancers
Blanchard TG,Czinn SJ,Banerjee V,Sharda N,Bafford AC,Mubariz F,Morozov D,Passaniti A,Ahmed H,Banerjee A
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Western Blot
Fri Feb 08 00:00:00 UTC 2019
A role for RASSF1A in tunneling nanotube formation between cells through GEFH1/Rab11 pathway control.
Cell communication and signaling : CCS
Dubois F,Jean-Jacques B,Roberge H,Bénard M,Galas L,Schapman D,Elie N,Goux D,Keller M,Maille E,Bergot E,Zalcman G,Levallet G
14-6888 was used in Immunocytochemistry-immunoflourescence to show that loss of RASSF1A expression could be a potential biomarker for tunnelling nanotube formation.
Thu Oct 11 00:00:00 UTC 2018
Upregulation of RASSF1A in Colon Cancer by Suppression of Angiogenesis Signaling and Akt Activation.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Blanchard TG,Lapidus R,Banerjee V,Bafford AC,Czinn SJ,Ahmed H,Banerjee A
14-6888 was used in Western Blotting to evaluate a regulatory link between angiogenesis and the down regulation of tumour suppressor genes in colon cancer.
Fri Sep 14 00:00:00 UTC 2018
RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation.
Oncotarget
Yang J,Platt LT,Maity B,Ahlers KE,Luo Z,Lin Z,Chakravarti B,Ibeawuchi SR,Askeland RW,Bondaruk J,Czerniak BA,Fisher RA
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Western Blot
Tue Oct 25 00:00:00 UTC 2016
Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma.
Scientific reports
Xue WJ,Feng Y,Wang F,Guo YB,Li P,Wang L,Liu YF,Wang ZW,Yang YM,Mao QS
Fri Feb 26 00:00:00 UTC 2016
DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
Neuro-oncology
Marzese DM,Scolyer RA,Roqué M,Vargas-Roig LM,Huynh JL,Wilmott JS,Murali R,Buckland ME,Barkhoudarian G,Thompson JF,Morton DL,Kelly DF,Hoon DS
14-6888 was used in Western Blotting to present an integrated genomic and epigenomic analysis that reveals melanoma brain metastases specific molecular alterations and mutually exclusive molecular subtypes.
Sat Nov 01 00:00:00 UTC 2014
RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression.
Molecular and cellular biology
Ram RR,Mendiratta S,Bodemann BO,Torres MJ,Eskiocak U,White MA
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Western Blot
Sun Jun 01 00:00:00 UTC 2014
RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression.
Molecular and cellular biology
Ram RR,Mendiratta S,Bodemann BO,Torres MJ,Eskiocak U,White MA
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Western Blot
Sun Jun 01 00:00:00 UTC 2014
5-Aza-2''-deoxycytidine inhibits retinoblastoma cell by reactivating epigenetically silenced RASSF1A gene.
International journal of ophthalmology
Liu R,Zhang XH,Zhang K,Li W,Wang WJ,Luo DX,Gao L
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Immunohistochemistry
Mon Mar 17 00:00:00 UTC 2014
Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosis.
The Biochemical journal
Recino A,Sherwood V,Flaxman A,Cooper WN,Latif F,Ward A,Chalmers AD
14-6888 was used in Immunofluorescence to propose that, owing to its key role in regulating the microtubule cytoskeleton, RASSF7 is required for mitosis in human cells.
Wed Sep 01 00:00:00 UTC 2010
Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
Molecular cell
Palakurthy RK,Wajapeyee N,Santra MK,Gazin C,Lin L,Gobeil S,Green MR
14-6888 was used in Western Blotting to delineate the mechanism by which HOXB3 epigenetically silences RASSF1A, and indicate this is a critical aspect of HOXB3's oncogenic activity.
Fri Oct 23 00:00:00 UTC 2009
Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.
Molecular cell
Palakurthy RK,Wajapeyee N,Santra MK,Gazin C,Lin L,Gobeil S,Green MR
14-6888 was used in Western Blotting to delineate the mechanism by which HOXB3 epigenetically silences RASSF1A, and indicate this is a critical aspect of HOXB3's oncogenic activity.
Fri Oct 23 00:00:00 UTC 2009
RASSF1A, BLU, NORE1A, PTEN and MGMT expression and promoter methylation in gliomas and glioma cell lines and evidence of deregulated expression of de novo DNMTs.
Brain pathology (Zurich, Switzerland)
Lorente A,Mueller W,Urdangarín E,Lázcoz P,Lass U,von Deimling A,Castresana JS
Published figure using RASSF1A monoclonal antibody (Product # 14-6888-82) in Western Blot
Wed Apr 01 00:00:00 UTC 2009
Molecular markers of tumor progression in melanoma.
Current genomics
Rother J,Jones D
14-6888 was used in Immunohistochemistry to discuss the interactions between point mutation in growth signaling molecules and epigenetic changes in genes involved in DNA repair and cell division.
Mon Jun 01 00:00:00 UTC 2009
Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells.
Oncogene
Man C,Rosa J,Lee LT,Lee VH,Chow BK,Lo KW,Doxsey S,Wu ZG,Kwong YL,Jin DY,Cheung AL,Tsao SW
14-6888 was used in Western Blotting to demonstrate that downregulation of RASSF1A expression by LMP1 may facilitate transformation of premalignant nasopharyngeal epithelial cells into cancer cells.
Thu May 10 00:00:00 UTC 2007
Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
Cancer research
Reu FJ,Leaman DW,Maitra RR,Bae SI,Cherkassky L,Fox MW,Rempinski DR,Beaulieu N,MacLeod AR,Borden EC
14-6888 was used in Western Blotting to identify RASSF1A as regulated by IFNs and participating in IFN-induced apoptosis at least in part by sensitization to TRAIL.
Wed Mar 01 00:00:00 UTC 2006
The RASSF1A tumor suppressor activates Bax via MOAP-1.
The Journal of biological chemistry
Vos MD,Dallol A,Eckfeld K,Allen NP,Donninger H,Hesson LB,Calvisi D,Latif F,Clark GJ
14-6888 was used in Immunoprecipitation to identify a novel pro-apoptotic pathway linking K-Ras, RASSF1A and Bax that is specifically impaired in some human tumors.
Fri Feb 24 00:00:00 UTC 2006
RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression.
Cancer research
Whang YM,Kim YH,Kim JS,Yoo YD
Sun May 01 00:00:00 UTC 2005
RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics.
Cancer research
Dallol A,Agathanggelou A,Fenton SL,Ahmed-Choudhury J,Hesson L,Vos MD,Clark GJ,Downward J,Maher ER,Latif F
Tue Jun 15 00:00:00 UTC 2004